Valion Bio stockholders authorize 1-for-5 to 1-for-50 reverse stock split

Valion Bio, Inc.

Special meeting Aug 14, 2026: reverse split proposal approved with 1,243,530 for, 697,127 against, 60,678 abstain.
Board has 12 months to set split ratio within 1-for-5 to 1-for-50 range without further stockholder approval.
Quorum was 48.21% (2,001,335 of 4,151,259 outstanding common shares represented).
Adjornment proposal also passed (1,242,980 for) but not used since Proposal 1 passed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.